Medspira Receives New Round of Funding

E-mail Print PDF


Share

Healthcare IT news Medical Device Innovator to Commercialize New Clinically Inspired Devices

September 7, 2011—Minneapolis—Medspira, an innovative medical device company, has received a $2,250,000 investment from a private venture group to build on the success of its flagship Breath Hold respiratory motion monitoring system and bring additional clinically-inspired medical technologies to market.

“We’re extremely pleased to receive funding to expand our efforts to seek out and commercialize innovative new medical devices that fill recognized needs in today’s healthcare environment,” said Jim Quackenbush, CEO of Medspira.  Quackenbush notes that Medspira’s mission is to bring specialized medical technologies developed in clinical settings to the mainstream medical market for the benefit of healthcare professionals and their patients.

Medspira works with renowned researchers, scientists, physicians and inventors primarily based in large research institutions to refine and market devices that fill a genuine gap in the physician’s armamentarium of tools to address key medical needs. All our offerings have proven themselves in a clinical setting and have already gained clinical acceptance,” Quackenbush adds. “Medspira brings to these technologies a demonstrated product development expertise and focused distribution model to ensure fast time-to-market and broad-based product exposure to appropriate physicians.” “This new funding provides an important validation of Medspira’s business model as well as the company’s initial efforts in support of the Breath Hold product,” he says.

Medspira’s breakthrough Breath Hold system enables physicians to compensate for the impact of breathing on lesion localization in the lungs and upper abdomen. Medspira Breath Hold enables patients to consistently reproduce the same breath-hold reference point by providing them with instant feedback on their breathing cycle. It has applications in the delivery of radiation therapy, image-guided biopsies and other imaging-driven procedures.  The device is based on technology developed by and licensed from Mayo Clinic.

Pointing out that respiratory motion affects a broad range of medical procedures, from diagnostic imaging to image-guided biopsies, Quackenbush notes that Breath Hold takes a novel and effective approach to compensating for the problem.  He says that while it was developed and originally marketed for biopsy applications, physicians have driven its expansion into a far broader range of uses.

“The success of Breath Hold clearly illustrates our vision for the company--to identify promising technologies developed in a clinical environment and contribute the marketplace-driven insight and expertise to facilitate widespread adoption,“ he says. Medspira’s new funding will support introduction of new technologies invented at Mayo Clinic and licensed to Medspira as part of the original license agreement in 2009.

About Medspira:

Since 2009, Medspira has worked with leading medical institutions to develop and market medical devices that provide cost effective diagnosis and treatment for a variety of conditions. Its highly focused distribution model addresses United States and worldwide markets. Products are produced in partnership with world-class, FDA approved and ISO 13485 registered manufacturing facilities.  Medspira was originally formed through the acquisition of product lines and technologies developed by Mayo Clinic. The company also maintains close relationships with major research organizations to track products that will fulfill its mission to bring important tools to more physicians, clinics and patients.

Media Contact:

Molly McDougall

HealthFlash Marketing

1234 Summer Street

Stamford, CT   06905

888-655-3434

molly@healthflashmarketing.com


Share
These signals are relayed buying clomid online safe which then is by a number of such as medial preoptic and paraventricular nulcei.
javporn.cc
Array
(
    [type] => 2048
    [message] => Non-static method JResponse::sendHeaders() should not be called statically
    [file] => /home/hihadmin/public_html/libraries/joomla/environment/response.php
    [line] => 206
)